FMED stock forecast, quote, news & analysis

FMED sees MACD Histogram crosses below signal line

FMED saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 01, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 33 instances where the indicator turned negative. In 29 of the 33 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 88%.

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for FMED moved out of overbought territory on August 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In 15 of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 35 of 40 cases where FMED's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 88%.

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FMED as a result. In 46 of 54 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMED declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

Bullish Trend Analysis

Following a +0.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where FMED advanced for three days, in 166 of 199 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

FMED may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 121 of 142 cases where FMED Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.